Capital Guardian Trust’s Novartis NVS Stock Holding History

Capital Guardian Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$12.9M	Sell	142,162 -11,779	-8%	-$997K	0.17%	130
2019 Q1	$13.2M	Buy	153,941 +9,929	+7%	+$797K	0.18%	121
2018 Q4	$11.1M	Buy	144,012 +5,484	+4%	+$427K	0.18%	121
2018 Q3	$10.7M	Buy	138,528 +17,275	+14%	+$1.28M	0.14%	126
2018 Q2	$8.21M	Buy	121,253 +4,930	+4%	+$340K	0.12%	129
2018 Q1	$8.43M	Buy	116,323 +16,530	+17%	+$1.26M	0.12%	137
2017 Q4	$7.51M	Buy	+99,793	New	+$7.53M	0.11%	147
2017 Q2	–	Sell	-176,077	Closed	-$11.7M	–	440
2017 Q1	$11.7M	Sell	176,077 -15,635	-8%	-$1.04M	0.09%	163
2016 Q4	$12.5M	Sell	191,712 -47,986	-20%	-$3.11M	0.1%	156
2016 Q3	$17M	Sell	239,698 -110,371	-32%	-$8.04M	0.13%	150
2016 Q2	$25.9M	Buy	350,069 +9,478	+3%	+$655K	0.2%	130
2016 Q1	$22.1M	Sell	340,591 -59,324	-15%	-$4.04M	0.17%	131
2015 Q4	$30.8M	Buy	399,915 +8,636	+2%	+$686K	0.24%	125
2015 Q3	$32.2M	Buy	391,279 +35,325	+10%	+$3.14M	0.26%	118
2015 Q2	$31.4M	Buy	355,954 +27,334	+8%	+$2.51M	0.23%	127
2015 Q1	$29M	Sell	328,620 -19,595	-6%	-$1.74M	0.22%	128
2014 Q4	$28.9M	Buy	348,215 +51,920	+18%	+$4.3M	0.2%	118
2014 Q3	$25M	Buy	296,295 +30,810	+12%	+$2.49M	0.18%	117
2014 Q2	$21.5M	Buy	265,485 +28,808	+12%	+$2.27M	0.15%	127
2014 Q1	$18M	Buy	236,677 +36,856	+18%	+$2.69M	0.12%	138
2013 Q4	$14.4M	Buy	199,821 +38,944	+24%	+$2.71M	0.09%	146
2013 Q3	$11.1M	Buy	160,877 +18,703	+13%	+$1.24M	0.08%	157
2013 Q2	$9.01M	Buy	+142,174	New	+$9.25M	0.06%	162

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Capital Guardian Trust's NVS Position: Q2 2019 in Review

Capital Guardian Trust reduced its Novartis (NVS) stake by 7.7% in Q2 2019, selling an estimated $997K and leaving 142,162 shares worth $12.9M. The position accounts for 0.17% of the portfolio, ranked #130.

Capital Guardian Trust first reported a position in NVS in Q2 2013 and has held it in 23 quarters since. The position peaked at $32.2M in Q3 2015. 1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2019.

Capital Guardian Trust held 142,162 shares of Novartis worth $12.9M as of Q2 2019.
Capital Guardian Trust sold 11,779 Novartis shares in Q2 2019, an estimated $997K.
Novartis made up 0.17% of Capital Guardian Trust's portfolio in Q2 2019, its #130 holding.
Capital Guardian Trust first reported a position in Novartis in Q2 2013 and has held it in 23 quarters since.
Capital Guardian Trust's Novartis position peaked at $32.2M in Q3 2015.
1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.